Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Exploris 240
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): B Cell
DISEASE(S): Acute Leukemia
SUBMITTER: Ronen Gabizon
LAB HEAD: Nir London
PROVIDER: PXD038375 | Pride | 2023-03-11
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
1267_1.raw | Raw | |||
1267_2.raw | Raw | |||
1267_3.raw | Raw | |||
1267_4.raw | Raw | |||
1342_1.raw | Raw |
Items per page: 5 1 - 5 of 196 |
Reddi Rambabu N RN Rogel Adi A Gabizon Ronen R Rawale Dattatraya Gautam DG Harish Battu B Marom Shir S Tivon Barr B Arbel Yamit Shorer YS Gurwicz Neta N Oren Roni R David Keren K Liu Jingjing J Duberstein Shirly S Itkin Maxim M Malitsky Sergey S Barr Haim H Katz Ben-Zion BZ Herishanu Yair Y Shachar Idit I Shulman Ziv Z London Nir N
Journal of the American Chemical Society 20230204 6
Electrophiles for covalent inhibitors that are suitable for in vivo administration are rare. While acrylamides are prevalent in FDA-approved covalent drugs, chloroacetamides are considered too reactive for such purposes. We report sulfamate-based electrophiles that maintain chloroacetamide-like geometry with tunable reactivity. In the context of the BTK inhibitor ibrutinib, sulfamate analogues showed low reactivity with comparable potency in protein labeling, in vitro, and cellular kinase activi ...[more]